Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration.
Johnston, Stephen S
Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration. [electronic resource] - Advances in therapy Dec 2013 - 1111-27 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
1865-8652
10.1007/s12325-013-0078-4 doi
Age Factors
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Cohort Studies
Cost-Benefit Analysis
Databases, Factual
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Health Care Costs
Humans
Intravitreal Injections
Linear Models
Male
Middle Aged
Multivariate Analysis
Poisson Distribution
Ranibizumab
Receptors, Vascular Endothelial Growth Factor--administration & dosage
Recombinant Fusion Proteins--administration & dosage
Retrospective Studies
Risk Assessment
Severity of Illness Index
Sex Factors
Time Factors
Treatment Outcome
United States
Vascular Endothelial Growth Factor A--administration & dosage
Wet Macular Degeneration--diagnosis
Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration. [electronic resource] - Advances in therapy Dec 2013 - 1111-27 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
1865-8652
10.1007/s12325-013-0078-4 doi
Age Factors
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Cohort Studies
Cost-Benefit Analysis
Databases, Factual
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Health Care Costs
Humans
Intravitreal Injections
Linear Models
Male
Middle Aged
Multivariate Analysis
Poisson Distribution
Ranibizumab
Receptors, Vascular Endothelial Growth Factor--administration & dosage
Recombinant Fusion Proteins--administration & dosage
Retrospective Studies
Risk Assessment
Severity of Illness Index
Sex Factors
Time Factors
Treatment Outcome
United States
Vascular Endothelial Growth Factor A--administration & dosage
Wet Macular Degeneration--diagnosis